An accelerated diagnostic protocol for the early, safe discharge of low-risk chest pain patients

Abstract

Clinical Question Can an accelerated 2-hour diagnostic protocol using the cardiac troponin I (cTnI) measurement as the only biomarker be implemented to allow an earlier and safe discharge of low-risk chest pain patients? Article Chosen Than M, Cullen L, Aldous S, et al. 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol 2012; 59(23):2091-8. Objective To determine whether an accelerated diagnostic protocol (ADP) for possible cardiac chest pain could identify lowrisk patients suitable for early discharge using cTnI as the sole biomarker.